Navigation Links
Pro-Dex, Inc. Appoints Harold A. Hurwitz Chief Executive Officer
Date:2/25/2013

IRVINE, Calif., Feb. 25, 2013 /PRNewswire/ -- PRO-DEX, INC. (NasdaqCM: PDEX) announced today that its Board of Directors voted unanimously to combine the roles of Chief Executive Officer and Chief Financial Officer and appointed Harold A. Hurwitz to the position of Chief Executive Officer effective immediately.  Mr. Hurwitz will retain his position as the Company's Chief Financial Officer. He succeeds Michael J. Berthelot , who had served as the Company's Chief Executive Officer since April 2012.

(Logo: http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

Mr. Hurwitz, 61, has served as the Company's Chief Financial Officer since 2010. From 2008 to 2010, Mr. Hurwitz was Vice President and Chief Financial Officer for Interventional Spine Inc., a medical device company focused on percutaneous systems for treatment of back pain.  Prior to that, he was a Principal Consultant with McDermott & Bull, a retained executive search firm, where he specialized in serving the life science industry.   From 1997 through 2004, Mr. Hurwitz was Vice President and Chief Financial Officer for Micro Therapeutics, Inc., a developer and manufacturer of interventional neurovascular medical devices, now part of Covidien plc.  Mr. Hurwitz began his career with Coopers & Lybrand, L.L.P., now part of PricewaterhouseCoopers LLP, where he served for 22 years, leading its life science and high technology practices in Orange County.

Nick Swenson , Chairman of the Company's Board of Directors, commented, "Pro-Dex seeks to embrace the scale-enabled qualities of great small companies, such as flexibility and the potential of any one employee to understand the character, capability, and personality of any other company employee. We
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
4. Pro-Dex, Inc. Announces Update Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
6. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
7. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
8. Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
9. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
10. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
11. Nephros Appoints John C. Houghton as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... DIEGO , May 4, 2015 ... oncology company focused on the clinical development of ... data showing mitochondria-specific effects of the Company,s investigational ... enhanced anti-tumor activity when combined with a tyrosine-kinase ... found ME-344 to be a potent inhibitor of ...
(Date:5/4/2015)... the cuvette manufacturing world, opened their doors to the public in early 2015.  In ... scientists amazing support for their spectroscopy needs.  ... ... ... In mid-2014 Simcha Woitovich ...
(Date:5/4/2015)... May 4, 2015 Dyadic International, Inc. ... patented and proprietary technologies are used to develop, ... the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme ... financial results for quarter ending March 31, 2015 ... and will host a conference call that day ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
(Date:5/4/2015)... 2015 New findings released today from ... (ABTA) show that people diagnosed with a brain tumor ... including clinical trials, at the time of diagnosis, and ... decisions about their course of treatment. The release of ... nationwide brain tumor volunteer network, the ABTA CommYOUnity™, dedicated ...
(Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
(Date:5/4/2015)... 2015 New West Medicare is excited ... LLC to manage outpatient advanced imaging services for its ... ensure its members are provided the right test at ... closely with New West Medicare’s physicians and hospitals, Care ... of advanced imaging and provide an objective basis for ...
(Date:5/4/2015)... NJ (PRWEB) May 04, 2015 Dr. ... he has been chosen to receive the America’s Best ... Dr. Champagne’s selection as a top dentist is ... commitment to continuing education and his compassion for his ... selects professionals who exemplify excellence in their field. These ...
Breaking Medicine News(10 mins):Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2
... ... Bill McKee,s Role Expanded, MONTVALE, N.J., March ... the restructuring of its,senior management team to better align the ... the global organization. Barr,s Chairman and Chief Executive,Officer, Bruce L. ...
... omega-3,polyunsaturated fatty acids (PUFAs) continue to prove their ... recent research summarized in the March,2008 Fats of ... show that omega-3s may improve recovery from,spinal cord ... of fish oil consumption on arterial elasticity, which ...
... of the California Department of Health Service,s Medi-Cal Managed Care ... widespread health care disparities based on ethnicity, race and language ... are bearing the brunt of it. , ... for the state,s minority populations, resulting in poorer health for ...
... March 27 A new survey shows that more ... cloned food after,the recent approval of the Food and ... Seas Research, 77.8 percent of,respondents said they were unsure ... making a decision. Many respondents referred to,Dolly, the first ...
... On March 25, 2008, The Honorable Dan,A. Polster, ... Liability Multi-District Litigation in the Northern District,of Ohio, ... Steering,Committee. One of these lawyers is Peter Burg ... Polster, and is responsible for conducting,pre-trial proceedings on ...
... the leader in,physician education for cardiac CT imaging, ... reduce the radiation dose to patients during,a CT ... CTA,are in the low dose ranges, well below ... health risk. However, if physicians and technologists are ...
Cached Medicine News:Health News:Barr Announces Reorganization of Senior Management, Business Functions 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 3Health News:Barr Announces Reorganization of Senior Management, Business Functions 4Health News:Barr Announces Reorganization of Senior Management, Business Functions 5Health News:Barr Announces Reorganization of Senior Management, Business Functions 6Health News:Barr Announces Reorganization of Senior Management, Business Functions 7Health News:Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes 2Health News:Study finds widespread care disparities in Medi-Cal program 2Health News:Study finds widespread care disparities in Medi-Cal program 3Health News:CVCTA Education Announces New LOW DOSE Initiative for CT Angiograms 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: